Novartis Pharma GmbH (release of the finished medicinal product)/Novartis Pharmaceuticals, S.A. (release of the finished medicinal product)
UkraineAll medications by this manufacturer
-
Simulect
Form: powder for solution for injection/infusion
Active substance Dosage basiliximab 20 mg ATC: L04AC02